Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

257
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Off-label prescribing in ophthalmology: a retrospective analysis.

Frontiers in pharmacology·2026
Same author

A unified clearance-based model of homeostatic drive across acute and chronic sleep loss.

Bio Systems·2026
Same author

Chemophysical Characterization of Carotenoproteins From Crustacean Shell Waste for Pharmaceutical Applications.

International journal of food science·2026
Same author

Effects of New P2X7R Antagonists on Retinal Inflammatory Degenerative Conditions.

Inflammation·2026
Same author

Activity dependent neuroprotective protein mediates the protective effects against VEGF-induced corneal barrier disruption in diabetes.

Peptides·2026
Same author

Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological tools.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Oct 5, 2025

Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.4K

Caffeine Protects Against Retinal Inflammation.

Federica Conti1, Francesca Lazzara1, Giovanni Luca Romano1,2

  • 1Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Catania, Italy.

Frontiers in Pharmacology
|January 24, 2022
PubMed
Summary

Caffeine, a popular stimulant, shows protective effects against retinal inflammation. It reduces inflammatory markers and preserves retinal function and integrity in both cell models and animal studies.

Keywords:
BDNFcaffeineinflammationretinaretinal pigment epithelial cells

More Related Videos

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
07:37

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

Published on: July 14, 2016

15.3K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.2K

Related Experiment Videos

Last Updated: Oct 5, 2025

Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.4K
A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
07:37

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure

Published on: July 14, 2016

15.3K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.2K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pharmacology

Background:

  • Caffeine is a widely consumed central nervous system stimulant.
  • It acts as an antagonist for A1 and A2A adenosine receptors.
  • Retinal inflammation is a significant factor in various eye diseases.

Purpose of the Study:

  • To investigate the potential protective effects of caffeine in retinal tissue.
  • To evaluate caffeine's efficacy in both in vitro and in vivo models of retinal inflammation.

Main Methods:

  • In vitro: Human retinal pigment epithelial cells (ARPE-19) treated with lipopolysaccharide (LPS) and caffeine.
  • In vivo: Ischemia reperfusion (I/R) injury model in C57BL/6J mice with topical caffeine treatment.
  • Assays included measuring inflammatory cytokines (IL-1β, IL-6, TNF-α), p-NFκB translocation, transepithelial electrical resistance (TEER), sodium fluorescein permeability, pattern electroretinogram (PERG), and BDNF levels.

Main Results:

  • Caffeine attenuated inflammatory responses in ARPE-19 cells by reducing cytokine release and p-NFκB nuclear translocation.
  • Caffeine treatment restored the integrity of the ARPE-19 cell monolayer.
  • In the I/R mouse model, caffeine maintained physiological levels of Brain-Derived Neurotrophic Factor (BDNF) and reduced IL-6 mRNA levels.
  • Caffeine treatment preserved retinal ganglion cell (RGC) function as assessed by PERG.

Conclusions:

  • Caffeine demonstrates significant anti-inflammatory properties in retinal tissue.
  • These findings suggest caffeine's potential as a therapeutic agent for managing retinal inflammation and associated diseases.
  • Further research into caffeine's role in ocular health is warranted.